PUBLIC COMPANY
saveVanderbilt-Ingram Cancer Center
updated 5mo ago
community read0 votes
🐶 often sniffed alongside
top 5pipeline
0
marketed
0
phase 3
0
catalysts ytd
1
approvals ytd
0
recalls ytd
0
Pipeline(0)
no pipeline products on record
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase1Casdatifan for the Treatment of Refractory Metastatic Clear Cell Renal Cell Carcinoma
- phase2Chemoprevention of Gastric Carcinogenesis
- phase2Lazarus: IT Therapy for ICANS
- phase2Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers
- N/AHigh-Resolution PET-CT Imaging for Surgical Margin Visualization
- N/ANavigation Endoscopy to Reach Indeterminate Lung Nodules Versus Trans-Thoracic Needle Aspiration
- phase2Pembrolizumab After Radiation Therapy and Chemotherapy in Limited Stage Small Cell Lung Cancer
- phase4Chimeric Antigen Receptor (CAR) T Cell Therapy With YESCARTA in the Outpatient Setting
🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that